MedPath

Evaluation of efficacy of Ritalin and ferrous sulfate in non-iron deficient children with attention-deficit/hyperactivity disorder (ADHD)

Phase 2
Conditions
Attention-deficit/hyperactivity disorder.
Disturbance of activity and attention
Registration Number
IRCT201512262639N17
Lead Sponsor
Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Age range of 6-11 years; having ADHD based DSM-IV criteria; having at least score of 20 in ADHD diagnostic rating scale via parent interview; No iron deficiency (serum hemoglobin, iron and ferritin levels in normal limits); Not receiving iron combinations within the past two months; No use of any ADHD therapy
Exclusion criteria: Acute or chronic medical disorders; epilepsy; tic; severe birth asphyxia; severe neonatal jaundice; vision problems; hearing disorders; other psychiatric disorders; irregular drugs usage; discontinuation of iron usage for more than one week

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ADHD diagnostic rating scale. Timepoint: Before and three months after treatment. Method of measurement: Parent interview.;Parent Conner rating scales. Timepoint: Before and three months after treatment. Method of measurement: Parent interview.
Secondary Outcome Measures
NameTimeMethod
Efficacy in more than 50% of reduction in ADHD diagnostic rating scale. Timepoint: Three months after treatment. Method of measurement: Parent interview.;Clinical side effects. Timepoint: Monthly until three months after treatment. Method of measurement: Asking from parents.
© Copyright 2025. All Rights Reserved by MedPath